Strengthening Neuroscience Clinical Research Through Innovation

Presented by

Juliet Moritz and Barry Dussault

About this talk

There’s a lot of discussions these days about innovative ideas to make clinical research more patient-focused. The concept goes hand-in-hand with the development of technology that permits researchers to design and execute trials that can significantly reduce the burden of participation. Development of neuroscience drugs is benefiting from these advances in patient-focused research, as new technologies and approaches are challenging traditional research models. This webinar will explore innovative technology being used to collect data in neuroscience trials, including wearables, remote medication compliance monitoring, data analytics and even virtual study visits to enhance compliance, data quality and patient-centricity. In this free webinar, the featured speakers will discuss: • How new technologies can make neuroscience trials more productive, efficient and the endpoints more objective • How these technologies can improve patient engagement and reduce patient burden, while raising new regulatory/operational concerns • How new technologies such as wearable devices, remote monitoring, and virtual patient visits have the potential to make trials more patient-friendly, whilst improving the speed and reliability of the studies •How social media provides many opportunities to increase patient engagement
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (96)
Subscribers (4583)
Premier Research is a clinical research company, dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.